75180-46-0 Usage
Uses
Used in Pharmaceutical Industry:
C-[1-(4-FLUORO-PHENYL)-CYCLOPROPYL]-METHYLAMINE is used as a building block for the synthesis of novel therapeutic agents targeting CNS disorders. Its unique structural features and the presence of a fluorine substituent in the phenyl ring contribute to its potential as a valuable component in the development of pharmaceuticals with CNS activity.
Used in Medicinal Chemistry Research:
C-[1-(4-FLUORO-PHENYL)-CYCLOPROPYL]-METHYLAMINE is used as a promising candidate for further research and development in medicinal chemistry. Its unique structural features and potential applications in the field of CNS activity make it an interesting subject for exploration and innovation in the development of new pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 75180-46-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,1,8 and 0 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 75180-46:
(7*7)+(6*5)+(5*1)+(4*8)+(3*0)+(2*4)+(1*6)=130
130 % 10 = 0
So 75180-46-0 is a valid CAS Registry Number.
75180-46-0Relevant academic research and scientific papers
Lewis Basic Sulfide Catalyzed Electrophilic Bromocyclization of Cyclopropylmethyl Amide
Wong, Ying-Chieh,Ke, Zhihai,Yeung, Ying-Yeung
supporting information, p. 4944 - 4947 (2015/11/03)
A Lewis basic sulfide catalyzed electrophilic bromocyclization of cyclopropylmethyl amide has been developed. The catalytic protocol is applicable to both 1,1- and 1,2-substituted cyclopropylmethyl amides, giving oxazolines and oxazines in good yields and excellent diastereoselectivity.
Positive Allosteric Modulators of MGLUR2
-
Paragraph 0080, (2013/09/26)
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds modulate the mGluR2 receptor and may be useful for the treatment of various disorders of the centr
